The results of a new study show that Ubamatamab, a bispecific antibody drug, has shown excellent results and a good safety profile in patients with ovarian cancer.
Search results for
"Findings"
-
-
Latest real-world data published, providing real evidence of the effectiveness of Azulfidine in patients with COVID-19